Product Code: ETC8285755 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Partial Androgen Insensitivity Syndrome Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Partial Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 Mexico Partial Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Partial Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of partial androgen insensitivity syndrome in Mexico |
4.2.2 Advances in medical research leading to improved treatment options |
4.2.3 Growing healthcare infrastructure and access to specialized care for patients with the syndrome |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals trained in treating partial androgen insensitivity syndrome |
4.3.2 High cost of treatment and medications for the syndrome |
4.3.3 Social stigma and lack of societal acceptance impacting patient care and treatment outcomes |
5 Mexico Partial Androgen Insensitivity Syndrome Market Trends |
6 Mexico Partial Androgen Insensitivity Syndrome Market, By Types |
6.1 Mexico Partial Androgen Insensitivity Syndrome Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.4 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen or Testosterone Therapy, 2021- 2031F |
6.1.5 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Partial Androgen Insensitivity Syndrome Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Injectables, 2021- 2031F |
6.2.3 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Partial Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Mexico Partial Androgen Insensitivity Syndrome Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Mexico Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Partial Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 Mexico Partial Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 Mexico Partial Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 Mexico Partial Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for patients with partial androgen insensitivity syndrome |
8.2 Number of healthcare facilities offering specialized care for the syndrome |
8.3 Patient satisfaction with the quality of care and support received for managing partial androgen insensitivity syndrome |
9 Mexico Partial Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 Mexico Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Mexico Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Mexico Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Mexico Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Partial Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 Mexico Partial Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Mexico Partial Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |